Devises / KURA
KURA: Kura Oncology Inc
6.30
USD
0.14
(2.17%)
Le taux de change de KURA a changé de -2.17% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 6.21 et à un maximum de 6.55.
Suivez la dynamique Kura Oncology Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KURA Nouvelles
- Seeking Alpha Kura: Ziftomenib Shift To Newly Diagnosed Mutant AML Patients Bodes Well (NASDAQ:KURA)
- Investing Kura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US
- Investing Cantor Fitzgerald reiterates overweight rating on Kura Oncology stock
- Investing Kura Oncology stock maintains Overweight rating on AML treatment progress
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing H.C. Wainwright reiterates buy rating on Kura Oncology stock at $40
- Investing Citizens JMP reiterates Kura Oncology stock rating on positive trial data
- Investing Kura Oncology at Goldman Sachs Conference: Strategic Insights on ZIFTOMENIB
- Investing Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Investing Kura Oncology at Jefferies Conference: Strategic Advancements in AML
- Investing **citizens jmp reiterates market outperform rating on kura oncology stock**
- Investing Leerink Partners reiterates outperform rating for Kura Oncology stock
- Investing Cantor Fitzgerald reiterates overweight rating for Kura Oncology stock
- Investing Kura Oncology at ASCO: Strategic Moves in AML Treatment
- Investing Kura Oncology reports positive trial results for AML treatment
- Investing H.C. WAINWRIGHT REITERATES BUY RATING ON KURA ONCOLOGY STOCK
- Investing Citizens JMP highlights key ASCO presentations
- Investing Kura Oncology at TD Cowen Summit: Strategic Innovations in Menin Inhibitors
- Investing Cantor Fitzgerald maintains Overweight on Kura Oncology stock
- Investing Kura Oncology to Participate in Three Upcoming Investor Conferences
- Seeking Alpha Syndax Pharmaceuticals: Down But Not Out (NASDAQ:SNDX)
- Benzinga Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - American Axle & Mfg Hldgs (NYSE:AXL), Alumis (NASDAQ:ALMS)
- Seeking Alpha Kura Oncology: Market Sees A Tough Road Ahead, But There's An Opportunity
- Seeking Alpha Kura Oncology, Inc. (KURA) Q4 2024 Earnings Call Transcript
Range quotidien
6.21
6.55
Range Annuel
5.41
21.57
- Clôture Précédente
- 6.37
- Ouverture
- 6.44
- Bid
- 6.30
- Ask
- 6.60
- Plus Bas
- 6.21
- Plus Haut
- 6.55
- Volume
- 2.574 K
- Changement quotidien
- -2.17%
- Changement Mensuel
- 9.76%
- Changement à 6 Mois
- -18.29%
- Changement Annuel
- -69.40%
31 juillet, jeudi
11:30
USD
- Act
- Fcst
- Prev
- 47.999 K
11:30
USD
- Act
- Fcst
- -68.3%
- Prev
- -1.6%
12:30
USD
- Act
- Fcst
- 0.4%
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 2.6%
- Prev
- 2.7%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.3%
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- -0.1%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- -0.4%
12:30
USD
- Act
- Fcst
- 0.0%
- Prev
- -0.3%
12:30
USD
- Act
- Fcst
- 0.9%
- Prev
- 0.9%
12:30
USD
- Act
- Fcst
- 1.0%
- Prev
- 1.2%
12:30
USD
- Act
- Fcst
- 0.7%
- Prev
- 0.8%
12:30
USD
- Act
- Fcst
- 224 K
- Prev
- 217 K
12:30
USD
- Act
- Fcst
- 1.966 M
- Prev
- 1.955 M
12:30
USD
- Act
- Fcst
- 222.299 K
- Prev
- 224.500 K
13:45
USD
- Act
- Fcst
- 42.4
- Prev
- 40.4
14:00
USD
- Act
- Fcst
- 2.3%
- Prev
- 2.0%
14:30
USD
- Act
- Fcst
- 2 B
- Prev
- 23 B
15:30
USD
- Act
- Fcst
- Prev
- 4.245%
15:30
USD
- Act
- Fcst
- Prev
- 4.265%